Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?-Reference-Cited by-同舟云学术

Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?

Published:2020-04-07 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Chocarro de Erauso Luisa,Zuazo Miren,Arasanz Hugo,Bocanegra Ana,Hernandez Carlos,Fernandez Gonzalo,Garcia-Granda Maria Jesus,Blanco Ester,Vera Ruth,Kochan Grazyna,Escors David

Funder

Fundación Científica Asociación Española Contra el Cáncer

Instituto de Salud Carlos III

Departamento de Educación, Gobierno de Navarra

Horizon 2020 Framework Programme

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference128 articles.

1. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

2. The Immunoscore: Colon Cancer and Beyond;Angell;Clin. Cancer Res.,2020

3. PD1 signal transduction pathways in T cells;Arasanz;Oncotarget,2017

4. Systemic immunological biomarkers of clinical responses in immune checkpoint blockade therapies;Arasanz;Lung Cancer Manag.,2018

5. Early detection of hyperprogressive disease in non-small cell lung cancer by monitoring of systemic T cell dynamics;Arasanz;Cancers,2020

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Latest Look at PDT and Immune Checkpoints;Current Issues in Molecular Biology;2024-07-08

2. Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee;Journal for ImmunoTherapy of Cancer;2024-07

3. Navigating the landscape of PD-1/PD-L1 imaging tracers: from challenges to opportunities;Frontiers in Medicine;2024-06-07

4. A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study;Clinical Lung Cancer;2024-05

5. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non–Small Cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and Japan;JCO Global Oncology;2024-03